November 18, 2026
Health news, explained with evidence
LIVE

Artificial Intelligence and Blood Tests Show Promise in Early Lung Cancer Detection

🧠 AI Analysis 2 min read 👁 4

Researchers at the Cancer Research UK National Biomarker Centre are combining advanced artificial intelligence with blood-based liquid biopsies to improve early detection methods for lung cancer.

Artificial Intelligence and Blood Tests Show Promise in Early Lung Cancer Detection🧠AI Analysis

Photo: Medical Xpress

Key points

  • Researchers are investigating AI-powered blood tests to detect early lung cancer signals.
  • The approach aims to complement existing mobile CT scan programs and improve screening accuracy.
  • Scientists hope liquid biopsies could eventually help identify tumors in populations currently ineligible for standard screening.

Investigators at the Cancer Research UK National Biomarker Centre are exploring innovative ways to refine lung cancer screening using artificial intelligence and blood analysis. While current National Health Service mobile CT screening initiatives successfully detect early-stage tumors in high-risk groups such as current and former smokers, medical experts note that existing approaches still face challenges including false positives, radiation exposure limits, and the exclusion of individuals who have never smoked.

To address these limitations, a team led by center director Professor Caroline Dive CBE, in collaboration with Wythenshawe Hospital's Professor Phil Crosbie, is investigating whether blood tests, or liquid biopsies, can supplement standard imaging. Early-stage malignancies shed microscopic cellular fragments, DNA, RNA, and proteins into the bloodstream. However, isolating these specific cancer indicators from billions of other blood components presents a massive data challenge.

By applying sophisticated machine learning algorithms to complex biological samples, researchers hope to uncover subtle molecular signatures that indicate the presence of an early tumor or predict which initial-stage cancers carry a higher risk of relapse. Scientists emphasize that this work remains in the investigative phase and is not yet a diagnostic tool available for clinical practice.

What to know: Researchers are studying whether AI-driven blood tests can enhance the accuracy of lung cancer screening and help identify hidden malignancies sooner. Always consult a qualified healthcare provider for personal medical advice and screening decisions.

Source Medical Xpress — medicalxpress.com/news/2026-11-ai-early-lung-cancer-blood.html ↗

Contact the newsroom

Got a tip, a proposal or a partnership question? Write to us and we will reply shortly.